Circadian Therapeutics aims to develop therapeutics and diagnostics for modulation of the body's circadian rhythms.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford Sciences Innovation's latest fundraising rounds off year which saw Oxford University Innovation launch 22 new spinout companies.
Oxford University forms spinout company to bring fast, cost-effective enzyme development to market.
Oxford University spinouts Genomics and Nanopore partner on utilising handheld nanopore technologies for DNA sequencing.
Mexican superfood startup Azure wins inaugural Humanities Innovation Challenge.
Atopix Therapeutics Limited, a UK biotechnology company with roots back to Oxford University, has been acquired by Italian pharmaceutical firm Chiesi Farmaceutici Spa.